MedPath

The effect endometrial thickening with Medroxyprogesterone Acetate on pregnancy rate in the women with recurrent implantation failure

Phase 2
Conditions
Female infertility.
Female infertility of uterine origin, Nonimplantation of ovum
Registration Number
IRCT2017020227311N3
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
23
Inclusion Criteria

women aged 20-40?
willingness to participate in the study?
lack of pregnancy in inclusion time?
endometrial thickness less than 8 milimeter by trans vaginal ultrasound?
minimum 1 year unexplained infertility history or more than 3 times of repeated failure of implantation ?
normal semen analysis according to WHO criteria.
Exclusion criteria:
willingness to use assisted reproductive technology?
use of hormones in 1 month ago?
debilitating disease of the ovary such as polycystic ovarian syndrome.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: Before intervention and after intervention. Method of measurement: Transvaginal ultrasound.;Pregnancy rate. Timepoint: After interventin. Method of measurement: Gravindex test and transvaginal ultrasound.;Relationship between endometrial thickness and pregnancy rate. Timepoint: Before and after intervention. Method of measurement: Gravindex test and transvaginal ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath